News | Oncology Diagnostics | April 05, 2018

Myriad Receives Pre-Market Approval for BRACAnalysis Diagnostic System in Japan

Indicated as a companion diagnostic for Lynparza (olaparib) for use in patients with metastatic inoperable or recurrent breast cancer

April 5, 2018 — Myriad Genetic Laboratories Inc. announced that the Japanese Ministry of Health, Labour and Welfare has granted manufacturing and marketing approval for Myriad’s BRACAnalysis Diagnostic System to be used as a companion diagnostic with the PARP inhibitor, Lynparza.  Lynparza is marketed by AstraZeneca and Merck, known as MSD outside the United States and Canada.

AstraZeneca and Merck are seeking approval of Lynparza in Japan for treating patients with BRCA-mutated metastatic breast cancer. BRACAnalysis is the first and only diagnostic test for a PARP inhibitor to receive regulatory approval in Japan. The test is marketed in the United States as BRCAnalysis CDx.

Currently there are about 40,000 patients with metastatic disease that would be eligible for BRACAnalysis testing in Japan, with an estimated 15,000 new cases of HER2-negative breast cancer diagnosed each year. Myriad will commercialize BRACAnalysis in exclusive partnership with the SRL Inc., a subsidiary of Miraca Group, and one of the largest laboratory service providers in Japan.

BRACAnalysis is a diagnostic system that classifies a patient’s clinically significant variants (DNA sequence variations) in the BRCA1 and BRCA2 genes. Variants are classified into one of the five categories — “Deleterious,” “Suspected Deleterious,” “Variant of Uncertain Significance,” “Favor Polymorphism” or “Polymorphism.” Once the classification is completed, the results are sent to medical personnel in Japan for determining the eligibility of patients for treatment with Lynparza.

BRACAnalysis CDx was approved by the U.S. Food and Drug Administration (FDA) in December 2014 for patients with advanced ovarian cancer, and again in January 2018 for patients with HER2-negative metastatic breast cancer.

For more information: www.myriad.com

 

Related Content

ABUS: An Important Companion to Traditional Mammography

The multi-use ultrasound breast system Acuson S2000 Automated Breast Volume Scanner (ABVS) from Siemens Healthineers automatically acquires volume images of the breast. Photo courtesy of Siemens.

Feature | Ultrasound Women's Health | April 18, 2018 | Emily Clemons
Research shows that automated br...
DenseBreast-info.org Celebrates Third Anniversary
News | Breast Density | April 17, 2018
April 2018 marks the third anniversary of the launch of DenseBreast-info.org, the educational resource for medically...
Technology | Breast Density | April 13, 2018
Densitas Inc. has received U.S. Food and Drug Administration (FDA) clearance for its DENSITAS|density automated breast...
Volpara Solutions and Mammography Educators Launch Mammography Positioning Training Videos
News | Mammography | April 12, 2018
Volpara Solutions Inc. and mammography education provider Mammography Educators LLC announced the launch of training...
Ikonopedia Introduces Enhanced Breast Ultrasound Reporting Module at SBI
News | Ultrasound Women's Health | April 11, 2018
Ikonopedia will introduce its next-generation breast ultrasound reporting module at the 2018 Society for Breast Imaging...
ACR/SBI Breast Cancer Screening Guidelines Reclassify African-American Women as High-Risk
News | Breast Imaging | April 06, 2018
New American College of Radiology (ACR) and Society of Breast Imaging (SBI) breast cancer screening guidelines are the...
Wisconsin Gov. Walker Signs Breast Density Reporting Bill
News | Breast Density | April 05, 2018 | Jeff Zagoudis, Associate Editor
Wisconsin Gov. Scott Walker made the Badger State the 35th state to report dense breast tissue to patients as part of...
Diagnosing Breast Cancer Using Red Light

Schematic diagram for OM instrument: Seven pulsed lasers sequentially illuminate the compressed breast; transmitted light is detected by the 8-channel SiPM probe and the TDC acquires the signal. Credit: Edoardo Ferocino

News | Breast Imaging | April 02, 2018
Optical mammography (OM), which uses harmless red or infrared light, has been developed for use in conjunction with X-...
News | Endoscopes | April 02, 2018
Results from a recent prospective trial found the Wide Area Transepithelial Sampling with 3D Tissue Analysis (WATS3D)...
ACR Recommends More Aggressive Breast Cancer Screening for Higher-Than-Average-Risk Women
News | Breast Imaging | March 29, 2018
The American College of Radiology (ACR) released new breast cancer screening guidelines recommending all women,...
Overlay Init